Cellectar Biosciences, Inc. Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cellectar Biosciences, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • Cellectar Biosciences, Inc. Return On Equity for the quarter ending June 30, 2024 was 1.16K %.
  • Cellectar Biosciences, Inc. annual Return On Equity for 2023 was 341 %.
  • Cellectar Biosciences, Inc. annual Return On Equity for 2022 was -212 %, a 255% decline from 2021.
  • Cellectar Biosciences, Inc. annual Return On Equity for 2021 was -59.8 %, a 4.7% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 1.16K +2.41K Apr 1, 2024 Jun 30, 2024
Q1 2024 637 +980 Jan 1, 2024 Mar 31, 2024
Q4 2023 341 +553 Oct 1, 2023 Dec 31, 2023
Q3 2023 704 +829 Jul 1, 2023 Sep 30, 2023
Q2 2023 -1.25K -1.17K -1342% Apr 1, 2023 Jun 30, 2023
Q1 2023 -343 -272 -381% Jan 1, 2023 Mar 31, 2023
Q4 2022 -212 -152 -255% Oct 1, 2022 Dec 31, 2022
Q3 2022 -125 -78.5 -168% Jul 1, 2022 Sep 30, 2022
Q2 2022 -86.9 -38.6 -79.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -71.3 -21.6 -43.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -59.8 +2.95 +4.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 -46.6 +71 +60.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -48.3 +79.4 +62.2% Apr 1, 2021 Jun 30, 2021
Q1 2021 -49.7 +86 +63.4% Jan 1, 2021 Mar 31, 2021
Q4 2020 -62.7 +56.9 +47.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 -118 -4.34 -3.83% Jul 1, 2020 Sep 30, 2020
Q2 2020 -128 -30.2 -30.9% Apr 1, 2020 Jun 30, 2020
Q1 2020 -136 -15.9 -13.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 -120 +5.57 +4.45% Oct 1, 2019 Dec 31, 2019
Q3 2019 -113 +22.3 +16.4% Jul 1, 2019 Sep 30, 2019
Q2 2019 -97.6 +85.3 +46.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 -120 +34.6 +22.4% Jan 1, 2019 Mar 31, 2019
Q4 2018 -125 +1.09 +0.86% Oct 1, 2018 Dec 31, 2018
Q3 2018 -136 -30.1 -28.5% Jul 1, 2018 Sep 30, 2018
Q2 2018 -183 -87.9 -92.6% Apr 1, 2018 Jun 30, 2018
Q1 2018 -154 -66.1 -74.8% Jan 1, 2018 Mar 31, 2018
Q4 2017 -126 -52.8 -72% Oct 1, 2017 Dec 31, 2017
Q3 2017 -106 -57 -117% Jul 1, 2017 Sep 30, 2017
Q2 2017 -94.9 -34.8 -57.8% Apr 1, 2017 Jun 30, 2017
Q1 2017 -88.3 +41.9 +32.2% Jan 1, 2017 Mar 31, 2017
Q4 2016 -73.4 +163 +69% Oct 1, 2016 Dec 31, 2016
Q3 2016 -48.6 +225 +82.2% Jul 1, 2016 Sep 30, 2016
Q2 2016 -60.1 +69.2 +53.5% Apr 1, 2016 Jun 30, 2016
Q1 2016 -130 +29 +18.2% Jan 1, 2016 Mar 31, 2016
Q4 2015 -237 +5.49 +2.27% Oct 1, 2015 Dec 31, 2015
Q3 2015 -273 +143 +34.4% Jul 1, 2015 Sep 30, 2015
Q2 2015 -129 +1.31K +91% Apr 1, 2015 Jun 30, 2015
Q1 2015 -159 +220 +58% Jan 1, 2015 Mar 31, 2015
Q4 2014 -242 -11.4 -4.95% Oct 1, 2014 Dec 31, 2014
Q3 2014 -417 -284 -215% Jul 1, 2014 Sep 30, 2014
Q2 2014 -1.44K -1.32K -1077% Apr 1, 2014 Jun 30, 2014
Q1 2014 -379 -272 -254% Jan 1, 2014 Mar 31, 2014
Q4 2013 -231 -137 -145% Oct 1, 2013 Dec 31, 2013
Q3 2013 -132 -38.7 -41.3% Jul 1, 2013 Sep 30, 2013
Q2 2013 -122 -21.5 -21.4% Apr 1, 2013 Jun 30, 2013
Q1 2013 -107 +9.35 +8.04% Jan 1, 2013 Mar 31, 2013
Q4 2012 -94 Oct 1, 2012 Dec 31, 2012
Q3 2012 -93.7 Jul 1, 2012 Sep 30, 2012
Q2 2012 -101 Apr 1, 2012 Jun 30, 2012
Q1 2012 -116 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.